SAM
EBS icon

Symphony Asset Management’s Emergent Biosolutions EBS Stock Holding History

Symphony Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-26,888
Closed -$977K – 371
2016
Q1 		$977K Buy
26,888
+6,818
+34% +$241K 0.11% 190
2015
Q4 		$803K Sell
20,070
-6,594
-25% -$230K 0.09% 214
2015
Q3 		$760K Buy
26,664
+12,465
+88% +$411K 0.09% 239
2015
Q2 		$468K Sell
14,199
-10,326
-42% -$320K 0.06% 289
2015
Q1 		$705K Buy
+24,525
New +$703K 0.08% 243

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Symphony Asset Management's EBS Position: Q2 2016 in Review

Symphony Asset Management sold out of Emergent Biosolutions (EBS) in Q2 2016, closing a stake of 26,888 shares — an estimated $977K sold.

Symphony Asset Management first reported a position in EBS in Q1 2015 and held it in 5 quarters. The position peaked at $977K in Q1 2016. 224 funds tracked by Wall St. Rank hold EBS as of Q2 2016.

  • Symphony Asset Management reported no remaining Emergent Biosolutions position as of Q2 2016 after selling out during the quarter.
  • Symphony Asset Management sold 26,888 Emergent Biosolutions shares in Q2 2016, an estimated $977K.
  • Symphony Asset Management first reported a position in Emergent Biosolutions in Q1 2015 and held it in 5 quarters.
  • Symphony Asset Management's Emergent Biosolutions position peaked at $977K in Q1 2016.
  • 224 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2016.

Based on Symphony Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.